In short. The subtypes of skin lupus, why sunlight drives it, and the systemic screening that has to accompany a skin diagnosis.
Key points
- Cutaneous lupus is a disease that changes.
- A person whose skin disease is well controlled may still develop systemic features later, and a person whose skin is quiet may need treatment adjusted for other reasons.
- Regular review and repeated screening are how those changes are caught early.
Lupus erythematosus is a disease in which the immune system attacks the body's own tissues, and the skin is one of its most frequent targets. When the disease is confined, or largely confined, to the skin it is called cutaneous lupus erythematosus. Examination and biopsy separate it into subtypes, and the subtype predicts both the appearance and the likelihood that other organs are involved.
The subtypes
Acute cutaneous lupus usually appears as a photosensitive rash across the cheeks and nose, and is strongly associated with systemic disease. Subacute cutaneous lupus produces ring-shaped or scaly, psoriasis-like lesions on sun-exposed shoulders, arms and trunk, and is often linked to circulating antibodies. Chronic cutaneous lupus, of which discoid lupus is the commonest form, produces well-defined scaly plaques that can scar and cause permanent hair loss when they involve the scalp. Lupus tumidus and chilblain lupus are less common variants.
Photosensitivity
Ultraviolet light is the single most important environmental trigger. In many patients, exposure to sun or to artificial ultraviolet sources provokes new lesions, worsens existing ones, and can even set off systemic symptoms. Protection is therefore treatment rather than advice: broad-spectrum sunscreen used generously and reapplied, protective clothing, hats, shade during the middle of the day, and care with windows and with fluorescent lighting in people who are markedly photosensitive. Smoking worsens cutaneous lupus and reduces the response to some treatments, which makes stopping part of the plan.
The systemic screening
A skin diagnosis does not exclude internal involvement, and the two are not reliably predicted by how the skin looks. Assessment therefore includes a full history for joint pain, mouth ulcers, hair loss, colour change in the fingers on cold exposure, chest pain, breathlessness and fatigue; urine testing for blood and protein; blood counts; and antibody testing including antinuclear antibodies and their specificities. Some subtypes carry a low risk and need only periodic review. Others, particularly acute cutaneous lupus, warrant closer and more frequent assessment with rheumatology involvement. This screening is repeated over time, because systemic features can appear later.
Treatment classes
Treatment begins with photoprotection and trigger avoidance, which are not optional extras. Topical corticosteroids and calcineurin inhibitors are used for limited disease, and local corticosteroid injections for resistant plaques. Antimalarial agents, principally hydroxychloroquine, are the foundation of systemic treatment for skin lupus and are effective in a large proportion of patients; they require eye monitoring because of a small risk of retinal toxicity, checked at baseline and periodically afterwards. Other agents, including methotrexate, mycophenolate, retinoids and biologics, are used when antimalarials are insufficient or not tolerated.
Why follow-up matters
Cutaneous lupus is a disease that changes. A person whose skin disease is well controlled may still develop systemic features later, and a person whose skin is quiet may need treatment adjusted for other reasons. Regular review and repeated screening are how those changes are caught early.
Seek prompt assessment if
- A new rash appears with fever, joint pain, chest pain or breathlessness.
- Urine changes colour or becomes frothy, or swelling appears in the legs or face.
- Discoid lesions are spreading on the scalp and hair is being lost in patches.
Frequently asked questions
What are the subtypes of cutaneous lupus?
Acute cutaneous lupus appears as a photosensitive rash across the cheeks and nose and is strongly associated with systemic disease. Subacute cutaneous lupus produces ring-shaped or scaly, psoriasis-like lesions on sun-exposed skin. Chronic cutaneous lupus, of which discoid lupus is the commonest form, produces scaly plaques that can scar and cause permanent hair loss on the scalp.
Why is sun protection described as treatment rather than advice?
Because ultraviolet light is the single most important environmental trigger. In many patients, exposure to sun or to artificial ultraviolet provokes new lesions, worsens existing ones, and can even set off systemic symptoms. Protection means generously applied broad-spectrum sunscreen, protective clothing, hats, shade in the middle hours, and care with windows.
What does the systemic screening look for, and why is it repeated?
It looks for joint pain, mouth ulcers, hair loss, colour change in the fingers in the cold, chest pain, breathlessness and fatigue, with urine testing for blood and protein, blood counts and antibody tests. It is repeated over time because systemic features can appear later, and skin appearance does not reliably predict them.
Risks & Limitations
- These are chronic conditions that are managed rather than cured, and flares are expected along the way.
- Immunosuppressive treatment raises the risk of infection and needs regular blood monitoring.
- Long-term systemic corticosteroids carry real side effects, including bone, metabolic and eye complications.
- Steroid-sparing agents and biologics have their own risks, including blood count, liver and kidney effects.
- Treatment is usually long term, and relapse is common when it is reduced or stopped.
- No treatment works for everyone, response cannot be predicted, and nothing here is guaranteed.
- Some scarring, pigment change and hair loss may be permanent even with good control.
When to Seek Care
- Widespread blistering, or raw eroded skin that is spreading — seek urgent care.
- Blistering or erosions in the mouth or throat that make eating or drinking difficult — seek urgent care.
- Fever with a rash, especially while on immunosuppressive treatment.
- Sudden severe skin pain or peeling of the skin — seek emergency care immediately.
- New breathlessness or chest pain, which may indicate involvement beyond the skin — seek emergency care.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- International Pemphigus & Pemphigoid Foundation — patient and clinical resources
- Cochrane Library — systematic reviews in dermatology
- Chinese Medical Association, Dermatology Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.